Shao-Hong Wang
Overview
Explore the profile of Shao-Hong Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
685
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huang Q, Wang G, Zhang Y, Zhang C, Ran Y, He J, et al.
Transl Res
. 2024 Nov;
275:48-61.
PMID: 39536938
According to morphological features, tumor-infiltrating B cells (TIL-Bs) can be classified as lympho-myeloid aggregates (LMAs) and tertiary lymphoid structures (TLSs). As a disease with high incidence and mortality, research on...
2.
Shi W, Chen D, Du Z, Liu C, Zhai T, Pan F, et al.
Cancer Cell Int
. 2024 Oct;
24(1):340.
PMID: 39402601
Background: Immune checkpoint blockade (ICB) has been improving the patient outcome in multiple cancer types. However, not all patients respond to ICB. Biomarkers are needed for selecting appropriate patients to...
3.
Li D, Cheng Y, Pan J, Guo Z, Wang S, Huang Q, et al.
J Pathol
. 2024 Feb;
263(1):74-88.
PMID: 38411274
Fascin actin-bundling protein 1 (Fascin) is highly expressed in a variety of cancers, including esophageal squamous cell carcinoma (ESCC), working as an important oncogenic protein and promoting the migration and...
4.
He J, Chen Y, Zeng F, Huang Q, Zhang H, Wang S, et al.
J Exp Clin Cancer Res
. 2023 May;
42(1):136.
PMID: 37254126
Background: Increasing evidence indicates that the tumor microenvironment (TME) is a crucial determinant of cancer progression. However, the clinical and pathobiological significance of stromal signatures in the TME, as a...
5.
Cao Y, Xie L, Tong B, Chu M, Shi W, Li X, et al.
Cell Death Differ
. 2022 Dec;
30(2):527-543.
PMID: 36526897
Anillin (ANLN) is a mitosis-related protein that promotes contractile ring formation and cytokinesis, but its cell cycle-dependent degradation mechanisms in cancer cells remain unclear. Here, we show that high expression...
6.
Zheng Z, Chu M, Lin W, Zheng Y, Xu X, Chen Y, et al.
Cell Death Dis
. 2022 May;
13(5):496.
PMID: 35614034
Esophageal squamous cell carcinoma (ESCC) is one of the world's leading causes of death, and its primary clinical therapy relies on surgical resection, chemotherapy, radiotherapy, and chemoradiotherapy. Although the genomic...
7.
Dinh H, Pan F, Wang G, Huang Q, Olingy C, Wu Z, et al.
Nat Commun
. 2021 Dec;
12(1):7335.
PMID: 34921160
The tumor microenvironment is a highly complex ecosystem of diverse cell types, which shape cancer biology and impact the responsiveness to therapy. Here, we analyze the microenvironment of esophageal squamous...
8.
Zheng Z, Yang P, Li R, Liu L, Xu X, Liao L, et al.
Cancer Lett
. 2021 Sep;
522:171-183.
PMID: 34571081
The clinical efficacy of cisplatin in the treatment of esophageal squamous cell carcinoma (ESCC) is undesirable. Signal transducer and activator of transcription 3β (STAT3β), a splice variant of STAT3, restrains...
9.
Cheng Y, Zeng F, Li D, Wang S, He J, Guo Z, et al.
Cancer Commun (Lond)
. 2021 Sep;
41(12):1398-1416.
PMID: 34555274
Background: Fascin is crucial for cancer cell filopodium formation and tumor metastasis, and is functionally regulated by post-translational modifications. However, whether and how Fascin is regulated by acetylation remains unclear....
10.
Liu W, Xie L, He Y, Wu Z, Liu L, Bai X, et al.
Nat Commun
. 2021 Aug;
12(1):4961.
PMID: 34400640
Esophageal cancer (EC) is a type of aggressive cancer without clinically relevant molecular subtypes, hindering the development of effective strategies for treatment. To define molecular subtypes of EC, we perform...